20240024686. ASYSTOLE AND COMPLETE HEART BLOCK DETECTION simplified abstract (West Affum Holdings DAC)

From WikiPatents
Jump to navigation Jump to search

ASYSTOLE AND COMPLETE HEART BLOCK DETECTION

Organization Name

West Affum Holdings DAC

Inventor(s)

Joseph L. Sullivan of Kirkland WA (US)

ASYSTOLE AND COMPLETE HEART BLOCK DETECTION - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240024686 titled 'ASYSTOLE AND COMPLETE HEART BLOCK DETECTION

Simplified Explanation

The abstract describes a patent application for a wearable cardioverter defibrillator (WCD) system. The system includes a support structure that can be worn by a patient, electrocardiogram (ECG) electrodes to obtain an ECG signal, and a processor to receive and analyze the ECG signal. The processor is capable of monitoring four or more channels of the ECG signal and can detect shockable events. The system also includes a high voltage subsystem with defibrillation electrodes that can deliver a therapeutic shock to the patient in response to a shockable event detected by the processor. The processor measures the peak-to-peak amplitude of QRS complexes in the ECG signal and can detect asystole (absence of heart activity) when the amplitude falls below a certain threshold.

  • The patent application describes a wearable cardioverter defibrillator (WCD) system.
  • The system includes a support structure, ECG electrodes, a processor, and a high voltage subsystem.
  • The processor can monitor four or more channels of the ECG signal and analyze it for shockable events.
  • The high voltage subsystem can deliver a therapeutic shock to the patient through defibrillation electrodes.
  • The processor measures the peak-to-peak amplitude of QRS complexes in the ECG signal.
  • The processor can detect asystole when the amplitude of one or more QRS complexes falls below a certain threshold.

Potential applications of this technology:

  • Emergency medical services: The wearable cardioverter defibrillator system can be used by paramedics or emergency medical technicians to provide immediate defibrillation to patients experiencing cardiac arrest.
  • Home healthcare: Patients with a high risk of sudden cardiac arrest can wear the WCD system at home, providing them with a portable and potentially life-saving device.
  • Cardiac rehabilitation: The WCD system can be used during cardiac rehabilitation programs to monitor patients' heart rhythms and provide defibrillation if necessary.

Problems solved by this technology:

  • Immediate response to cardiac arrest: The WCD system allows for quick detection of shockable events and the delivery of a therapeutic shock, potentially saving lives.
  • Continuous monitoring: The system can continuously monitor the patient's ECG signal, allowing for early detection of asystole and prompt intervention.

Benefits of this technology:

  • Portability: The wearable nature of the system allows patients to carry it with them, providing continuous monitoring and potential defibrillation wherever they go.
  • Early intervention: The system can detect shockable events and deliver a therapeutic shock promptly, increasing the chances of successful resuscitation.
  • Non-invasive monitoring: The ECG electrodes used in the system provide a non-invasive way to monitor the patient's heart rhythm, eliminating the need for invasive procedures.


Original Abstract Submitted

in one example, an apparatus of a wearable cardioverter defibrillator (wcd) system comprises a support structure wearable by a patient, a plurality of electrocardiogram (ecg) electrodes to obtain an ecg signal, a processor to receive and analyze the ecg signal of the patient, wherein the processor is configured to monitor four or more channels of the ecg signal, a high voltage subsystem coupled with defibrillation electrodes configured to be coupled with patient, wherein processor is configured to cause the high voltage subsystem to apply a therapeutic shock to the patient through the defibrillation electrodes in response to a shockable event detected by the processor from the ecg signal. the processor measures a peak-to-peak amplitude of qrs complexes of the ecg signal, and detects asystole in the patient when the peak-to-peak amplitude of one or more qrs complexes is less than an asystole threshold. other examples and related methods are disclosed herein.